Clinical Trial Update: A CR-UK Phase I Trial of LY3143921 [Phase 1]

View source ↗

Summary

Phase I trial update for LY3143921 sponsored by Cancer Research UK; the study is Active Not Recruiting and explores multiple cancer indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Esophageal Squamous Cell Carcinoma
• Head and Neck Squamous Cell Carcinoma
• High-grade Serous Ovarian Cancer
• Non-small Cell Lung Cancer
• Pancreatic Cancer
• Triple-negative Breast Cancer
• Urothelial Carcinoma

Drugs mentioned

• LY3143921

Snippet

Sponsor: Cancer Research UK | Conditions: A. Colorectal Cancer, B. High Grade Serous Ovarian Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING